Natrol has NADH exclusive in US market
A new stabilized NADH, a form of B vitamin niacin also known as coenzyme 1, is set to enter the US market under an exclusive patent licensing agreement between Natrol and Austria's Oekopharm.
A new stabilized NADH, a form of B vitamin niacin also known as coenzyme 1, is set to enter the US market under an exclusive patent licensing agreement between Natrol and Austria's Oekopharm.
The FDA has confirmed the qualified health claim linking whole grain barley to a reduced risk of coronary heart disease, which could help raise awareness of the grain amongst heart health-conscious consumers.
Natto, the traditional Japanese fermented soybean and a rich source of vitamin K2, could reduce bone loss in post-menopausal women by as much as 80 per cent, says research from Japan.
Cognis and WILD are joining forces to form a powerhouse of food and beverage product innovation, combining Cognis' store of ingredients with Wild's formulation expertise.
Dietary supplementation with an omega-3 enriched milk could be a simple and tolerable way to ease cardiovascular risk factors linked to metabolic syndrome, say Spanish researchers.
The debate about dairy consumption boosting weight loss got a massive fillip at the Paris Anti-Obesity Therapies congress, but natural product-based dietary supplements don't help weight loss said experts.
Danisco claims that ice cream with less than one per cent fat is possible thanks to new technology that prevents unwanted ice crystals from forming.
A chewing gum with the amino acid cysteine aimed at reducing the risk of alcohol and tobacco smoking related cancers is expected to launch to market this year, following extensive research at the University of Helskinki.